Clinical Significance of Detecting Tissue Factor and Tissue Factor Pathway Inhibitor in Thalassemia Patients.
- Author:
Hui LIU
1
;
Na SUN
1
;
Yu-Lan HUANG
1
;
Xie SU
1
;
Dong-Hong DENG
1
;
Peng CHENG
2
Author Information
- Publication Type:Journal Article
- From: Journal of Experimental Hematology 2018;26(5):1471-1476
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the changes of E-selectin, thrombin-antithrombin complex(TAT), prothrombin fragment 1+2(F1+2), tissue factor(TF)and tissue factor pathway inhibitor(TFPI)before and one year after splenectomy in thalassemia patients.
METHODSA total of 30 thalassemia patients undergoing electric laparoscopic splenectomy and 30 normal controls(NC) were enrolled in the study.Plasma levels of E-selectin, TAT, F1+2, TF and TFPI were detected by enzyme-linked immuno sorbent assay(ELISA).
RESULTSOne year after splenectomy,the plasma concentrations of E-selectin, TAT, F1+2, TF, TFPI were significantly higher than those in both preoperative and NC groups.Levels of E-selectin, TAT, F1+2 before splenectomy were significantly higher than those in NC groups. In addition, there was a positive correlation between plasma TF and TFPI level before and after splenectomy, and the levels of TF and TFPI positively correlated with TAT and F1+2, respectively.
CONCLUSIONAfter splenectomy, the platelet count increases, the activity of endothelial cells is injured, the procoagulant factor increases, the blood is in procoagulant state, the TF/TFPI shows an importent role in the thrombosis of thalassemia patieints after splenectomy and may be used to evaluate the prothrombotic state of this diasease.